EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
91 hedge funds and large institutions have $616M invested in Eidos Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
43% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 37
54% less call options, than puts
Call options by funds: $1.96M | Put options by funds: $4.25M
Holders
91
Holding in Top 10
3
Calls
$1.96M
Puts
$4.25M
Top Buyers
| 1 | +$12.1M | |
| 2 | +$5.28M | |
| 3 | +$1.87M | |
| 4 |
BlackRock
New York
|
+$1.83M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.76M |
Top Sellers
| 1 | -$6.45M | |
| 2 | -$5.36M | |
| 3 | -$3.14M | |
| 4 |
Renaissance Technologies
New York
|
-$2.34M |
| 5 |
Millennium Management
New York
|
-$1.94M |